Aprepitant in the Prevention of Cisplatin-induced Delayed Emesis
Status:
Terminated
Trial end date:
2012-05-01
Target enrollment:
Participant gender:
Summary
The aim of the study is to compare efficacy and tolerability of aprepitant plus dexamethasone
versus metoclopramide plus dexamethasone in the prevention of cisplatin-induced delayed
emesis in patients that received aprepitant, palonosetron and dexamethasone before
chemotherapy administration for the prevention of acute emesis.